Related Experiment Video
Updated: Feb 28, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
[Chronic HCV infection: An internist's opinion (Part 2)]
M L Zubkin1, V I Chervinko2, Yu V Ovchinnikov2
1G.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia; Branch, S.M. Kirov Military Medical Academy, Moscow, Russia.
Insights
Chronic Hepatitis C virus (HCV) infection is linked to endocrine and cardiovascular diseases beyond liver damage. This review examines these extrahepatic manifestations and current antiviral treatments.
Area of Science:
- Hepatology
- Virology
- Endocrinology
- Cardiology
Background:
- Hepatitis C virus (HCV) infection causes chronic hepatitis and severe liver conditions like cirrhosis and hepatocellular carcinoma.
- Beyond liver disease, chronic HCV infection is associated with numerous extrahepatic manifestations.
- Previous reviews covered lymphoproliferative and autoimmune disorders; this review focuses on endocrine and cardiovascular conditions.
Purpose of the Study:
- To analyze the association between chronic HCV infection and endocrine diseases, specifically thyroiditis and diabetes mellitus.
- To investigate the relationship between chronic HCV infection and cardiovascular disorders.
- To review current antiviral agents and their potential use in patients with HCV-related extrahepatic manifestations.
Main Methods:
- Literature review and analysis of scientific publications.
- Synthesis of data on endocrine and cardiovascular diseases linked to HCV.
- Evaluation of existing antiviral therapies for efficacy in extrahepatic disease contexts.
Main Results:
- Chronic HCV infection is significantly associated with the development of certain endocrine disorders, including thyroiditis and diabetes mellitus.
- Evidence suggests a link between chronic HCV infection and an increased risk of cardiovascular disorders.
- Current antiviral treatments offer potential therapeutic options for managing HCV, with ongoing research into their impact on extrahepatic manifestations.
Conclusions:
- Chronic HCV infection extends beyond hepatic complications, encompassing significant endocrine and cardiovascular risks.
- Understanding these extrahepatic manifestations is crucial for comprehensive patient management.
- Further research is needed to fully elucidate the role of antiviral therapies in mitigating HCV-associated extrahepatic diseases.
Abstract:
Hepatitis C virus (HCV) infection results in not only chronic hepatitis and subsequent complications as liver cirrhosis and hepatocellular carcinoma, but also in a significant number of other diseases, the so-called extrahepatic manifestations of chronic HCV infection. In addition to lymphoproliferative and autoimmune disorders discussed in Part 1 of this review, many other diseases turned to be associated with chronic HCV infection. Part 2 of this review is dedicated to the analysis of the relationship of chronic HCV-infection to the development of some endocrine diseases, such as thyroiditis and diabetes mellitus, and cardiovascular disorders. It also provides the characteristics of the currently available antiviral agents and considers whether they may be used in patents with extrahepatic manifestations of chronic HCV infection.
More Related Videos
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:30Acute Pancreatitis II: Clinical Manifestations and Management